Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Highlight Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 99
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 82
Rounds per year 9.90
Lead investments 25
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.16
Exits 5
Key employees 6

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Biopharma
Summary

Highlight Capital appeared to be the VC, which was created in 2014. The main department of described VC is located in the Nanjin. The company was established in Asia in China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Highlight Capital, startups are often financed by WI Harper Group, Qiming Venture Partners, Prometheus Capital. The meaningful sponsors for the fund in investment in the same round are Wu Capital, V Star Capital, Sequoia Capital China. In the next rounds fund is usually obtained by Aphelion Capital, Wu Capital, SDIC Fund Management.

The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Chemclin, Quyi Network, Imago BioSciences. We can highlight the next thriving fund investment areas, such as Biotechnology, Biopharma. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 19 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Highlight Capital performs on 26 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2013. The fund is generally included in 2-6 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Highlight Capital:
Typical Co-investors
Highlight Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Highlight Capital:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

EdgeRock

$15M08 Mar 2024 Wuqing, Tianjin, China

Shifan Microelectronics

$15M22 Feb 2024 Shenzhen, Guangdong, China

Hydropeng Technology

Battery
Manufacturing
$1M05 Feb 2024 Shenzhen, Guangdong, China

Aoli Biotechnology

Biopharma
Biotechnology
29 Jan 2024 Shenzhen, Guangdong, China

Tachem

Biotechnology
Health Care
Medical
$46M29 Nov 2023 Zigong, Sichuan, China

Hongce Precision

Intelligent Systems
Intrusion Detection
Semiconductor
08 Nov 2023 Shenzhen, Guangdong, China

Acchrom Tech

Health Care
Manufacturing
Medical Device
$15M29 May 2023 Huairou, Beijing, China

Rgenta Therapeutics

Biotechnology
Medical
Pharmaceutical
Therapeutics
$8M08 May 2023 Cambridge, Massachusetts, United States

Tripod Preclinical Research Laboratories

Biopharma
Pharmaceutical
$5M12 Apr 2023 Nanjing, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Highlight Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 99
Average round size 35M
Rounds per year 9.90
Peak activity year 2018
Lead investments 25
Follow on index 0.16
Exits 5
Group Appearance index 0.88

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

EdgeRock

$15M08 Mar 2024 Wuqing, Tianjin, China

Shifan Microelectronics

$15M22 Feb 2024 Shenzhen, Guangdong, China

Hydropeng Technology

Battery
Manufacturing
$1M05 Feb 2024 Shenzhen, Guangdong, China

Aoli Biotechnology

Biopharma
Biotechnology
29 Jan 2024 Shenzhen, Guangdong, China

Tachem

Biotechnology
Health Care
Medical
$46M29 Nov 2023 Zigong, Sichuan, China

Hongce Precision

Intelligent Systems
Intrusion Detection
Semiconductor
08 Nov 2023 Shenzhen, Guangdong, China

Acchrom Tech

Health Care
Manufacturing
Medical Device
$15M29 May 2023 Huairou, Beijing, China

Rgenta Therapeutics

Biotechnology
Medical
Pharmaceutical
Therapeutics
$8M08 May 2023 Cambridge, Massachusetts, United States

Tripod Preclinical Research Laboratories

Biopharma
Pharmaceutical
$5M12 Apr 2023 Nanjing, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: